Cargando…
High rifampicin peak plasma concentrations accelerate the slow phase of bacterial decline in tuberculosis patients: Evidence for heteroresistance
BACKGROUND: Antibiotic treatments are often associated with a late slowdown in bacterial killing. This separates the killing of bacteria into at least two distinct phases: a quick phase followed by a slower phase, the latter of which is linked to treatment success. Current mechanistic explanations f...
Autores principales: | Martinecz, Antal, Boeree, Martin J., Diacon, Andreas H., Dawson, Rodney, Hemez, Colin, Aarnoutse, Rob E., Abel zur Wiesch, Pia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128972/ https://www.ncbi.nlm.nih.gov/pubmed/37053266 http://dx.doi.org/10.1371/journal.pcbi.1011000 |
Ejemplares similares
-
Reaction Kinetic Models of Antibiotic Heteroresistance
por: Martinecz, Antal, et al.
Publicado: (2019) -
Estimating treatment prolongation for persistent infections
por: Martinecz, Antal, et al.
Publicado: (2018) -
A Population Pharmacokinetic Model Incorporating Saturable Pharmacokinetics and Autoinduction for High Rifampicin Doses
por: Svensson, Robin J., et al.
Publicado: (2017) -
Multi-scale modeling of drug binding kinetics to predict drug efficacy
por: Clarelli, Fabrizio, et al.
Publicado: (2019) -
Increased bactericidal activity but dose-limiting intolerability at 50 mg·kg(−1) rifampicin
por: te Brake, Lindsey H.M., et al.
Publicado: (2021)